X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1124) 1124
cd30 (752) 752
index medicus (652) 652
male (554) 554
female (530) 530
expression (458) 458
adult (431) 431
middle aged (405) 405
cd30 antigen (336) 336
pathology (334) 334
lymphomas (322) 322
aged (306) 306
immunohistochemistry (300) 300
oncology (292) 292
immunology (290) 290
hematology (253) 253
lymphoma (240) 240
ki-1 antigen - metabolism (228) 228
disease (222) 222
animals (220) 220
adolescent (195) 195
dermatology (186) 186
hodgkins-disease (179) 179
t cells (177) 177
reed-sternberg cells (172) 172
cancer (169) 169
ki-1 antigen - immunology (166) 166
soluble cd30 (165) 165
lymphocytes (159) 159
prognosis (157) 157
diagnosis (153) 153
anaplastic large cell lymphoma (150) 150
mice (150) 150
hemic and lymphatic diseases (142) 142
t-cells (141) 141
cd30 ligand (140) 140
brentuximab vedotin (137) 137
cytokines (134) 134
child (131) 131
ki-1 antigen - analysis (129) 129
receptor (129) 129
ki-1 antigen - blood (128) 128
skin neoplasms - pathology (128) 128
hodgkin's disease (127) 127
aged, 80 and over (121) 121
chemotherapy (115) 115
lymphoma, large-cell, anaplastic - pathology (114) 114
skin (112) 112
tumors (112) 112
diagnosis, differential (110) 110
flow cytometry (110) 110
cd30 expression (109) 109
analysis (108) 108
activation (107) 107
transplantation (105) 105
cell biology (104) 104
apoptosis (103) 103
lymphocytes t (103) 103
classification (102) 102
antigen (101) 101
hodgkin disease - pathology (101) 101
immune system diseases (98) 98
immunophenotyping (93) 93
non-hodgkin's lymphomas (93) 93
biopsy (92) 92
ki-1 antigen - genetics (90) 90
large-cell lymphoma (89) 89
treatment outcome (89) 89
anaplastic large-cell lymphoma (86) 86
lymphomatoid papulosis (86) 86
lymphoproliferative disorders (86) 86
t-cell lymphoma (85) 85
immunotherapy (83) 83
young adult (82) 82
care and treatment (81) 81
gene expression (81) 81
hodgkin lymphoma (79) 79
child, preschool (78) 78
surgery (77) 77
non-hodgkins-lymphoma (76) 76
research (76) 76
health aspects (75) 75
medicine & public health (74) 74
medicine, research & experimental (72) 72
lymphocytes b (71) 71
retrospective studies (71) 71
t-lymphocytes - immunology (71) 71
ki-1 antigen - biosynthesis (68) 68
antigens (67) 67
cell line, tumor (67) 67
article (66) 66
epstein-barr-virus (66) 66
lymphoma, large b-cell, diffuse - pathology (66) 66
survival (64) 64
ki-1 antigen (63) 63
leukemia (62) 62
mycosis fungoides (62) 62
antineoplastic agents - therapeutic use (61) 61
ligands (61) 61
patients (61) 61
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1610) 1610
German (13) 13
Japanese (10) 10
Korean (8) 8
Chinese (3) 3
Polish (3) 3
Russian (2) 2
Dutch (1) 1
Slovak (1) 1
Spanish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The American Journal of Surgical Pathology, ISSN 0147-5185, 09/2019, Volume 43, Issue 9, pp. 1191 - 1202
The presence of CD30 cells in cutaneous lymphomas has come to prominence in recent years as a potential diagnostic and therapeutic marker. In primary cutaneous... 
TRANSFORMATION | SURGERY | primary cutaneous marginal zone lymphoma | cutaneous-MALT lymphoma | Hodgkin-like cells | IMMUNOGLOBULIN | progression | CLASSIFICATION | CD30 expression | MUTATIONS | SKIN | PATHOLOGY
Journal Article
Modern Pathology, ISSN 0893-3952, 09/2015, Volume 28, Issue 9, pp. 1202 - 1213
Journal Article
Human Pathology, ISSN 0046-8177, 2016, Volume 60, pp. 160 - 166
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 12/2014, Volume 167, Issue 5, pp. 608 - 617
Summary Diffuse large B‐cell lymphoma (DLBCL) is a heterogeneous disease with variable therapeutic responses and alternative therapies are needed for patients... 
rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone therapy | CD30 | immunohistochemistry | diffuse large B‐cell lymphoma | Epstein‐Barr virus | Immunohistochemistry | Rituximab plus cyclophosphamide | Epstein-Barr virus | Prednisone therapy | Doxorubicin | Vincristine | Diffuse large B-cell lymphoma | SURVIVAL | vincristine | and prednisone therapy | HODGKIN | rituximab plus cyclophosphamide | diffuse large B-cell lymphoma | doxorubicin | HEMATOLOGY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Oligonucleotide Array Sequence Analysis | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Gene Expression Regulation, Neoplastic | Male | Gene Expression Profiling | Lymphoma, Large B-Cell, Diffuse - metabolism | Aged, 80 and over | Vincristine - administration & dosage | Adult | Retrospective Studies | British Columbia - epidemiology | Doxorubicin - administration & dosage | Ki-1 Antigen - biosynthesis | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Neoplasm Proteins - biosynthesis | Survival Rate | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Adolescent | Aged | Lymphomas | Corticosteroids
Journal Article
International Journal of Dermatology, ISSN 0011-9059, 07/2019, Volume 58, Issue 7, pp. 800 - 805
Background CD8+ lymphomatoid papulosis is frequently indistinguishable histopathologically from primary cutaneous aggressive epidermotropic CD8+ T‐cell... 
Mycoses | Mycosis fungoides | Non-Hodgkin's lymphomas | T cells | Analysis | Mycosis | Identification methods | CD8 antigen | Cytotoxicity | Fungal infections | Lymphoma | Lymphomatoid papulosis | CD5 antigen | CD30 antigen | Biopsy | Lymphomas | Diagnosis | Lesions | CD7 antigen
Journal Article
The Journal of Immunology, ISSN 0022-1767, 09/2006, Volume 177, Issue 5, pp. 3074 - 3081
Journal Article
Hematological Oncology, ISSN 0278-0232, 06/2019, Volume 37, Issue S2, pp. 281 - 283
Journal Article
Journal of Cutaneous Pathology, ISSN 0303-6987, 11/2019, Volume 46, Issue 11, pp. 823 - 829
Aims Brentuximab vedotin is a monoclonal anti‐CD30 antibody‐drug conjugate that has been used to treat a variety of CD30+ neoplasms. The phenomenon of antigen... 
anaplastic large cell lymphoma | loss of CD30 | brentuximab | CD30+ cutaneous T‐cell lymphoma | mycosis fungoides | CD20 | RITUXIMAB THERAPY | LARGE-CELL LYMPHOMA | PATHOLOGY | CD30+cutaneous T-cell lymphoma | DERMATOLOGY | Immunohistochemistry | Antigens | CD30 antigen | Tumor cells | CD20 antigen | Rituximab | Lymphomas | Anaplastic large-cell lymphoma | Tumors
Journal Article
Journal Article
Journal of Cutaneous Pathology, ISSN 0303-6987, 06/2019, Volume 46, Issue 6, pp. 447 - 451
Intravascular large B‐cell lymphoma (IVLBCL) is one of the rarest B‐cell non‐Hodgkin lymphomas (NHL), with an aggressive clinical behavior and a poor... 
RECEPTOR | DLBCL | MANAGEMENT | PATHOLOGY | CLINICAL PRESENTATION | DERMATOLOGY | Lymphomas | Biological products | Chemotherapy | CD30 antigen | Aggressive behavior | Lymphocytes B | Medical prognosis | Central nervous system | Lymphoid tissue | Lymphoma | Tumors | Hemopoiesis
Journal Article
Oncology Letters, ISSN 1792-1074, 02/2016, Volume 11, Issue 2, pp. 969 - 972
The majority of natural killer (NK)/T-cell lymphomas occur in the nasal cavity and rarely involve the stomach. They possess a specific immunophenotype, with... 
CD30 | Stomach | NK/T-cell lymphoma | CD56 | ENTEROPATHY | ONCOLOGY | NASAL-TYPE | DISEASE | stomach
Journal Article